Cargando…
A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
Switching macrophages from a pro-tumor type to an anti-tumor state is a promising strategy for cancer immunotherapy. Existing agents, many derived from bacterial components, have safety or specificity concerns. Here, we postulate that the structures of the bacterial signals can be mimicked by using...
Autores principales: | Feng, Yanxian, Mu, Ruoyu, Wang, Zhenzhen, Xing, Panfei, Zhang, Junfeng, Dong, Lei, Wang, Chunming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531447/ https://www.ncbi.nlm.nih.gov/pubmed/31118418 http://dx.doi.org/10.1038/s41467-019-10354-2 |
Ejemplares similares
-
A pocket-escaping design to prevent the common interference with near-infrared fluorescent probes in vivo
por: Xing, Panfei, et al.
Publicado: (2020) -
A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
por: Xie, Daping, et al.
Publicado: (2022) -
Air pollution particles hijack peroxidasin to disrupt immunosurveillance and promote lung cancer
por: Wang, Zhenzhen, et al.
Publicado: (2022) -
Tumor‐associated macrophages‐educated reparative macrophages promote diabetic wound healing
por: Mu, Ruoyu, et al.
Publicado: (2022) -
Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)